John Edward Greissing

Registered Lobbyist

Disclosed Prior Position

N/A

Lobby Filings

Clients

Firms

Years Active

2016–2026

Total Contributed

$1,000

Contributions

Recipients

Contrib Filings

Top Recipient Legislators

No matched legislators.

Top Committees / PACs

Payee	Count	Total
BUDDY CARTER FOR SENATE	1	$1,000

Lobbying Filings

All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Year	Firm	Client	Income
2026 1st Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2025 4th Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2025 3rd Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2025 2nd Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2025 1st Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2024 4th Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2024 3rd Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2024 2nd Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2024 1st Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—
2023 4th Quarter - Report	BIOMARIN PHARMACEUTICAL INC.	BIOMARIN PHARMACEUTICAL INC.	—

Page 1 of 4 · 40 filings Next

Recipient / Honoree	Legislator	Payee / Committee	Date	Amount
REP. BUDDY CARTER, CANDIDATE, U.S. SENATE	—	BUDDY CARTER FOR SENATE	Sep 29, 2025	$1,000

Year	Period	Posted	Status
2025	Year End	Jan 30, 2026	Active
2025	Mid Year	Jul 28, 2025	None
2024	Year End	Jan 29, 2025	None
2024	Mid Year	Jul 28, 2024	None
2023	Year End	Jan 29, 2024	None
2023	Mid Year	Jul 28, 2023	None
2022	Year End	Jan 29, 2023	None
2022	Mid Year	Jul 29, 2022	None
2021	Year End	Jan 29, 2022	None
2021	Mid Year	Jul 27, 2021	None
2020	Year End	Jan 30, 2021	None
2020	Mid Year	Jul 26, 2020	None
2019	Year End	Jan 24, 2020	None
2019	Mid Year	Jul 25, 2019	None
2018	Year End	Jan 27, 2019	None
2018	Mid Year	Jul 28, 2018	None
2017	Year End	Jan 24, 2018	None
2017	Mid Year	Jul 27, 2017	None
2016	Year End	Jan 29, 2017	None